ABOUT US
About AmoyDx History Certificates News & Events Staff Charisma Stock Information
PRODUCTS
NGS Assays Real-time PCR Assays FISH Assays Extraction
GLOBAL BUSINESS
Distributorship
SUPPORT
Customer Service
FAQs
DOWNLOAD
MEET US
MEET US
language
Search
HRD Focus 2019-nCoV NTRK HRR HANDLE Classic NGS Panel Pan Lung Cancer Essential NGS panel BRCA Multi-Gene Super-ARMS EGFR C797S KRAS NRAS ROS1 MET HPV
Log in
Log in
Search
HRD Focus 2019-nCoV NTRK HRR HANDLE Classic NGS Panel Pan Lung Cancer Essential NGS panel BRCA Multi-Gene Super-ARMS EGFR C797S KRAS NRAS ROS1 MET HPV
ABOUT US PRODUCTS GLOBAL BUSINESS SUPPORT MEET US
  • Better life with AmoyDx
    more
  • Better life with AmoyDx
    more
  • AmoyDx won the Second Prize of National Scientific and Technological Progress Award
    more
  • Better life with AmoyDx
    more
Scroll

ABOUT AMOYDX

Amoy Diagnostics Co., Ltd. (AmoyDx) focuses on molecular diagnostics for oncology precision medicine. With completely independent intellectual property rights of ADx-ARMS and Super-ARMS technologies, AmoyDx has a market-leading portfolio of molecular diagnostic kits including but not limited to EGFR, RAS, ALK, BRAF, PIK3CA and ROS1 testing kits, which were firstly approved by CFDA and CE certified. 

more
Better Life with AmoyDx

Latest News

Latest News more
13 /Nov

Highlights of China International Import Expo (CIIE) 2023 - Amoy Diagnostics Announced Multiple Collaborations with AstraZeneca and Pfizer

AmoyDx announced multiple collaborations with AstraZeneca and Pfizer during the 2023 China International Import Expo (CIIE), held on November 5-10 in Shanghai China. These partnerships aim to jointly promote the development of precision diagnostics

03 /Nov

AmoyDx® Microsatellite Instability (MSI) Detection Kit Received NMPA Approval for Pan-Tumor Immunotherapy Companion Diagnostics

National Medical Products Administration (NMPA) granted approval to AmoyDx® Microsatellite Instability (MSI) Detection Kit

15 /Aug

AmoyDx Collaborates with AstraZeneca to Develop a HER2 Companion Diagnostic for Lung Cancer in China

We are thrilled to announce that AmoyDx reaches a new collaboration agreement with AstraZeneca. Under this agreement, the AmoyDx® Essential NGS panel will be used as a companion diagnostic of ENHERTU® to identify HER2 (ERBB2) mutations in patients with no

27 /Mar

AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for selpercatinib RET fusion positive NSCLC

The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the AmoyDx® Pan Lung Cancer PCR Panel (the “AmoyDx PLC Panel”) as a companion diagnostic for RET fusion-positive non-small cell lung cancer (“NSCLC”), for selpercatinib capsules 40 mg

more

New Products

new product release

    New Products

    new product release

    • Pan Lung Cancer PCR Panel

    • HANDLE Classic NGS Panel

    • HRD Focus Panel

    • BRCA Pro Panel

    • PLC Pan Lung Cancer PCR Panel
      01
    • Classic HANDLE Classic NGS Panel
      02
    • HRD HRD Focus Panel
      03
    • BRCA Pro BRCA Pro Panel
      04
    1. 01
    2. 02
    3. 03
    4. 04

    • Pan Lung Cancer PCR Panel

    • HANDLE Classic NGS Panel

    • HRD Focus Panel

    • BRCA Pro Panel

    • PLC Pan Lung Cancer PCR Panel
      01
    • Classic HANDLE Classic NGS Panel
      02
    • HRD HRD Focus Panel
      03
    • BRCA Pro BRCA Pro Panel
      04
    1. 01
    2. 02
    3. 03
    4. 04

    • Pan Lung Cancer PCR Panel

    • HANDLE Classic NGS Panel

    • HRD Focus Panel

    • BRCA Pro Panel

    • PLC Pan Lung Cancer PCR Panel
      01
    • Classic HANDLE Classic NGS Panel
      02
    • HRD HRD Focus Panel
      03
    • BRCA Pro BRCA Pro Panel
      04
    1. 01
    2. 02
    3. 03
    4. 04

    • Pan Lung Cancer PCR Panel

    • HANDLE Classic NGS Panel

    • HRD Focus Panel

    • BRCA Pro Panel

    • PLC Pan Lung Cancer PCR Panel
      01
    • Classic HANDLE Classic NGS Panel
      02
    • HRD HRD Focus Panel
      03
    • BRCA Pro BRCA Pro Panel
      04
    1. 01
    2. 02
    3. 03
    4. 04
  1. NGS
  2. PCR
  3. FISH
  4. Extraction
    5. more
Support

ESMO Asia

https://www.esmo.org/meetings/esmo-asia-congress-2022

December 2-4, 2022
meet us

AMP

https://www.amp.org/events/amp-events-calendar/calendar/amp-2022-annual-meeting-expo/

November 3-5, 2022

  • Stock Info

    Stock info
  • 21.51 +%3.07
    Stock code：300685 Real-time data
  • View details
Inquiry
* Required information
Refresh the image
send
Manage your account info
  • Please Select
  • Mr.
  • Ms.
  • Dr.
  • Prof.
Submit
Change your password
Confirm Submission